OncoLab Co., Ltd. has been officially selected to deliver a Company Presentation at the BIO International Convention 2025 (BIO USA 2025)—the world’s largest and most influential biotechnology event.
BIO USA 2025 will be held June 16–19, 2025 at the Boston Convention & Exhibition Center (BCEC). The event brings together more than 17,000 participants from over 60 countries, including top biopharma executives, investors, academic researchers, and policymakers, making it the premier global stage for biotech partnering and innovation.
At the event, OncoLab will present its proprietary drug delivery platform, ANGel (Antibody-Conjugated NanoGel), designed to revolutionize precision immuno-oncology.
ANGel enables modular loading of diverse antibodies and therapeutic payloads, tumor microenvironment-specific activation, and sustained local release—integrated into a single platform aimed at transforming the treatment paradigm for solid tumors.
ANGel enables modular loading of diverse antibodies and therapeutic payloads, tumor microenvironment-specific activation, and sustained local release—integrated into a single platform aimed at transforming the treatment paradigm for solid tumors.
With science at our core and global expansion in our sights, OncoLab remains committed to advancing innovative therapies that extend survival and enhance quality of life for patients worldwide.
Event Details
Location: Boston Convention & Exhibition Center (BCEC), Boston, MA, USA
Date: June 16 (Mon) – June 19 (Thu), 2025
Session: Company Presentation – OncoLab Co., Ltd.
Date: June 16 (Mon) – June 19 (Thu), 2025
Session: Company Presentation – OncoLab Co., Ltd.